HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic infusion and local irrigation with argatroban effective in preventing clot formation during carotid endarterectomy in a patient with heparin-induced thrombocytopenia.

AbstractBACKGROUND:
A therapeutic dilemma exists when patients with symptomatic carotid stenosis and concomitant heparin-induced thrombocytopenia (HIT) are advised to urgently undergo carotid endarterectomy (CEA) with heparin therapy.
METHODS:
After a 63-year-old man with HIT and multiple medical comorbidities underwent emergent coronary artery bypass grafting, postoperative imaging revealed plaque at the origin of the left internal carotid artery with 80%-99% stenosis and minimal contralateral internal carotid artery disease. During the patient's evaluation to undergo CEA for symptomatic high-grade carotid stenosis, enzyme-linked immunosorbent assay revealed persistent platelet factor 4 antibodies.
RESULTS:
The endarterectomy was successfully performed while the patient received argatroban, both as a continuous infusion and intermittent irrigation during dissection of the plaque. Postoperatively, the drip was continued for 24 hours, and the patient was discharged day 2 on a daily dose of 325 mg of aspirin. At the 6-month examination, Doppler ultrasound revealed normal anterograde velocities with no evidence of stenosis, and the patient noted no subsequent ischemic events.
CONCLUSIONS:
We now recommend systemic intravenous and local argatroban irrigation to prevent thromboembolic complications in CEA cases with HIT and renal insufficiency. Bivalirudin for both systemic intravenous use and local irrigation may be safer in patients without renal insufficiency because of its shorter half-life.
AuthorsJoseph C Serrone, Norberto Andaluz, Victoria Brink, Mario Zuccarello, Susan L Ware
JournalWorld neurosurgery (World Neurosurg) 2013 Jul-Aug Vol. 80 Issue 1-2 Pg. 222.e15-8 ISSN: 1878-8769 [Electronic] United States
PMID23321376 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Anticoagulants
  • Pipecolic Acids
  • Sulfonamides
  • Heparin
  • Arginine
  • argatroban
Topics
  • Aged
  • Anticoagulants (administration & dosage, adverse effects, therapeutic use)
  • Arginine (analogs & derivatives)
  • Carotid Stenosis (pathology, surgery)
  • Cerebral Angiography
  • Endarterectomy, Carotid (methods)
  • Heparin (adverse effects, immunology)
  • Humans
  • Infarction, Middle Cerebral Artery (complications)
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Male
  • Pipecolic Acids (administration & dosage, therapeutic use)
  • Postoperative Period
  • Sulfonamides
  • Therapeutic Irrigation
  • Thrombocytopenia (chemically induced, drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: